UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
Morning Overview on MSN
New prostate cancer cell atlas may aid earlier detection, researchers say
A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...
A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...
Scientists from the Moffitt Cancer Center say they now have a better understanding why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings ...
A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...
Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially ...
Enara Bio, a pioneer in Dark Antigen(R) discovery and bispecific T cell engager innovation, today announced new data to be presented at the American Association for Cancer Research (AACR) Annual ...
Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
Morning Overview on MSN
Experimental prostate cancer drug shrinks tumors in early clinical trial
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results